In these patients, no significant correlation between CK20 mRNA detection in blood and overall survival (p = 0.776) as well as CK20 positivity in blood and tumor-specific survival (p = 0.593) could be assessed (data not shown). The gene discussed is KRT20; the disease is neoplasm.